课题基金 / 基金详情

Bone Tissue Engineering Using Mineralized Collagen-GAG Scaffolds

Bone Tissue Engineering Using Mineralized Collagen-GAG Scaffolds
使用矿化胶原蛋白-GAG 支架的骨组织工程
批准号:
8621974
负责人:
Timothy A Miller
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-10-01 至 2015-09-30

项目摘要

项目成果

Timothy A Miller的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 在过去的15年里,我们的实验室一直专注于合成骨移植替代品(BGS)的开发。我们的实验性骨移植替代物包括PLGA-(聚丙交酯-共-乙交酯)和胶原基支架,这些支架接种有自体骨髓基质细胞(BMSC),并由骨诱导剂(包括BMP-2)刺激。通过这些BGS模型,我们在体外(使用三维组织培养系统)和体内均生成了新骨,导致兔中临界尺寸颅骨缺损的愈合。虽然我们的研究很有希望,但临床上有用的BGS仍然难以捉摸。载体在BGS的发展中至关重要。PLGA显示出很大的前景,既生物相容性又可生物降解。然而,在组织工程中使用PLGA存在局限性。PLGA诱导酸性降解产物的形成,其可影响局部PH,可能诱导炎症。基于胶原蛋白的支架,包括胶原蛋白-GAG,已经广泛用于骨组织工程,因为胶原蛋白是细胞外基质的天然存在的组分,其促进细胞结合,表现出低抗原性并且具有优异的止血性质。我们证明,人类骨髓间充质干细胞(MSC)种植在胶原蛋白支架表现出加速和强大的矿化和骨形成相比,他们的同行种植在PLGA支架。然而,我们在体外研究中也发现,与PLGA支架相比,细胞接种的胶原支架发生显著收缩。这种收缩会极大地阻碍胶原植入物在修复骨缺损中的应用。为了限制胶原蛋白植入物的体积损失和破坏,我们建议通过在胶原蛋白-GAG原纤维上掺入纳米颗粒磷酸钙(CaP)来稳定胶原蛋白支架的结构。我们的初步试验结果表明,使用MC-GAG支架可以大大防止hMSCs粘附和分化引起的收缩。它在支持新骨形成方面也上级胶原-GAG。我们目前的建议是进一步研究MC-GAG支架在骨组织工程中的可行性。在这个建议中,我们将比较胶原蛋白-GAG和MC-GAG支架在体外培养的兔BMSCs中支持成骨分化的能力。我们还将通过对新形成的骨进行组织学和力学分析,比较由胶原-GAG和MC-GAG制成的细胞支架在愈合临界尺寸的兔颅骨缺损中的功效。最后,我们将研究整合素及其下游信号分子负责胶原蛋白-GAG和MC-GAG之间的差异,在他们的能力,以控制收缩和支持成骨分化的rBMSCs。我们预期MC-GAG支架将(1)与单独的胶原蛋白相比,增强兔BMSC的成骨分化并减少收缩,以及(2)与单独的胶原蛋白相比,加速兔颅骨缺损模型中的新骨形成。我们预计,整合素信号的变化是负责增强分化和减少MC-GAG支架中的rBMSC的收缩。
英文摘要
DESCRIPTION (provided by applicant): Our laboratory has been focused on the development of a synthetic bone graft substitute (BGS) for the past 15 years. Our experimental bone graft substitutes have included PLGA- (Poly-lactide-co-glycolide) and collagen-based scaffolds seeded with autologous bone marrow stromal cells (BMSC), and stimulated by osteoinductive agents including BMP-2. With these BGS models, we have generated new bone both in vitro, using a 3-dimensional tissue culture system, and in vivo, resulting in the healing of critical-sized cranial defects in the rabbit. While our studies have been promising, a clinically useful BGS remains elusive. The carrier is of critical importance in the development of a BGS. PLGA has shown much promise, being both biocompatible and biodegradable. However, there are limitations to the use of PLGA in tissue engineering. PLGA induces the formation of acidic degradation products that can affect local PH, possibly inducing inflammation. Collagen based scaffolds, including collagen-GAG, have been widely used in bone tissue engineering because collagen is a naturally existing component of extracellular matrix that promotes cell binding, exhibits low antigenicity and has excellent haemostatic property. We demonstrated that human mesenchymal stem cells (MSC) seeded in collagen scaffolds exhibit accelerated and robust mineralization and bone formation in comparison to their counterparts seeded in PLGA scaffolds. However, we also discovered in our in vitro studies that cell-seeded collagen scaffolds undergo significant contraction compared to PLGA scaffolds. The contraction can greatly hamper application of collagen implants in repairing bony defects. In order to limit volume loss and destruction of collagen implants, we propose to stabilize the structure of collagen scaffolds by incorporating nanoparticulate calcium phosphate (CaP) on the collagen-GAG fibrils. Our initial test results indicate using MC-GAG scaffolds can greatly prevent contraction caused by adhesion and differentiation of hMSCs. It is also superior to collagen-GAG in supporting new bone formation. Our current proposal intends to further investigate the feasibility of MC-GAG scaffolds in bone tissue engineering. In this proposal, we will compare collagen-GAG and MC-GAG scaffolds for their ability to support osteogenic differentiation in rabbit BMSCs cultured in vitro. We will also compare the efficacy of cellular scaffolds made of collagen-GAG and MC-GAG in healing a critical-sized rabbit cranial defect by performing histological and mechanical analysis of newly formed bone. Finally, we will study integrins and their downstream signaling molecules responsible for the differences between collagen-GAG and MC-GAG in their ability to control contraction and support osteogenic differentiation in rBMSCs. We expect that MC-GAG scaffolds will (1) enhance osteogenic differentiation and reduce contraction in rabbit BMSCs compared to collagen alone, and (2) accelerate new bone formation in a rabbit cranial defect model compared to collagen alone. We anticipate that changes in integrin signaling are responsible for enhanced differentiation and reduced contraction of rBMSCs in MC-GAG scaffolds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Learning Universal Patient Representations with Hierarchical Transformers
  • 批准号:
    10587270
  • 项目类别:
  • 资助金额:
    $64.82万
  • 财政年份:
    2019
  • 负责人:
    Timothy A Miller
  • 依托单位:
Automated domain adaptation for clinical natural language processing
  • 批准号:
    9768545
  • 项目类别:
  • 资助金额:
    $38.39万
  • 财政年份:
    2018
  • 负责人:
    Timothy A Miller
  • 依托单位:
Bone Tissue Engineering Using Mineralized Collagen-GAG Scaffolds
海外基金